| abstract |
The present invention relates to pharmaceutical combinations to compensate for an absolute and relative testosterone deficit in men with simultaneous prophylaxis for the development of benign prostatic hyperplasia (BPH) or prostate carcinoma. DOLLAR A The combinations according to the invention contain a natural or synthetic androgen in combination with a progestogen, an antestagen, an antiestrogen, a GnRH analogue, a testosterone 5alpha reductase inhibitor, an alpha-andrenoreceptor blocker or a phosphodiesterase inhibitor. DOLLAR A In comparison to the combinations according to the invention, each active ingredient alone cannot achieve the desired goal. |